U.S. Contract Research Organization (CROs) Market, by Service Type (Drug Discovery, Preclinical studies, Early Phase I – IIa, Phase IIa – III, Phase IIIb – IV, Drug Development, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statist

U.S. Contract Research Organization (CROs) Market, by Service Type (Drug Discovery, Preclinical studies, Early Phase I – IIa, Phase IIa – III, Phase IIIb – IV, Drug Development, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO (Small Size, Medium Size, and Large Size) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

A contract research organization (CRO) offers effective services to pharmaceutical and biotechnology organizations by reducing cost and time period required to conduct the clinical trial. The U.S. continues to be the one of the largest market for pharmaceutical research and development, thereby providing growth opportunities for contract research organizations (CROs). CROs offer drug discovery services such as drug target identification, drug discovery screening, library screening, fragment-based drug design, ligand-based drug design, ligand protein binding, drug profiling, lead identification, lead compound identification, and lead optimization. CROs conducts clinical trial studies (from phase I to phase IV). It is also engaged in medical coding, monitoring, clinical data management, protocol development, and other services which are included in clinical development of any drug molecules.
Market Dynamics
Rising number of U.S. Food and Drug Administration (FDA) approvals and clinical trials are supporting growth of biopharmaceutical industry are expected to fuel growth of the U.S. contract research organization (CROs) market. The U.S. is expected to hold dominant position in the contract research organization market over the forecast period due to rising demand for generic drugs, increasing clinical research and development activities, and government support. The U.S. is one of the biggest market for contract research organization due increasing pharmaceutical research and development activities in the country, thereby providing growth opportunities for contract research organizations (CROs). For instance, according to the clinicaltrials.gov, from September 2008 to October 2019, around 34% (125,000) of clinical trial studies were performed in the U.S. out of 317,865 studies, globally.
Key features of the study:
This report provides in-depth analysis of the U.S. contract research organization (CROs) market and provides market size (US$ Mn) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, pipeline drugs, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global U.S. contract research organization (CROs) market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
Key companies covered as a part of this study include Laboratory Corporation of America Holdings (Covance), IQVIA, Paraxel International Corporation, Syneos Health, PRA Health Sciences, Charles River Laboratoires International Inc. (CRL), Pharmaceutical Product Development (PPD), ICON Public Limited Corporation, Wuxi Apptec,Medpace Holdings, Inc,Medidata Solutions, Inc., Theorem Clinical Research, Pharmaron, Envigo, Clinipace, CMIC Holdings Co., Ltd, EPS International, Synteract, CROMSOURCE, Pharm-Olam, Linical Accelovance, Accumedix, Inc., AlcheraBio LLC, Amarex Clinical Research LLC, Arianne Corporation, Absolute Research Solutions, BioClinica Inc., BioPharma Services Inc., Neurovasc Preclinical Services, Inc., PSI, WCCT Global Inc., RHO, Inc., CATO Research LLC, Spaulding Clinical Research, Celerion, Clindatrix, Inc., Comparative Biosciences, Inc., Axiom Real-Time Metrics, CPC Clinical Research, Axis Clinicals LLC, DP Clinical, Egeen Inc., Grayline, Cmed, Integrium, LLC, MedTrials, Novum, Shin Nippon Biomedical Laboratories, Ltd., KPS Life, Pinnacle Research Group, LLC Promedica International., Alta Science, Prometrika, LLC, 4clinics, and Premier Research.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future product launches, market expansion, and marketing tactics
The global U.S. contract research organization (CROs) market report caters to various stakeholders in this industry, including investors, product developers, distributors, healthcare companies, research institutes, CROs, medical device companies, new entrants, and financial analysts
Stakeholders would greatly benefit in decision making through the various strategy matrices used in analyzing the U.S. contract research organization (CROs) market
Detailed Segmentation:
U.S. Contract Research Organization (CROs) Market, By Service Type:
Drug Discovery
Preclinical studies
Early Phase I - IIa
Phase IIa - III
Phase IIIb – IV
Drug Development
Medical Coding and Writing
Monitoring
Clinical Data Management
Bio-statistics
Site Management
Protocol Development
Biomarker Discovery
U.S. Contract Research Organization (CROs) Market, By Therapeutic Application:
Oncology
Cardiovascular Diseases
Central Nervous System Diseases
Infectious Diseases
Metabolic Disorders
Immunological Disorders
Respiratory Disorders
Others
U.S. Contract Research Organization (CROs) Market, By Size of CRO:
Small Size
Medium Size
Large Size
Company Profiles
Laboratory Corporation of America Holdings (Covance) *
Company Overview
Product Portfolio
Market Presence
Financial Overview
Key Developments
Strategies
IQVIA
Paraxel International Corporation
Syneos Health
PRA Health Sciences
Charles River Laboratoires International Inc. (CRL)
Pharmaceutical Product Development (PPD)
ICON Public Limited Corporation
Wuxi Apptec
Medpace Holdings, Inc
Medidata Solutions, Inc.
Theorem Clinical Research
Pharmaron
Envigo
Clinipace
CMIC Holdings Co., Ltd
EPS International
Synteract
CROMSOURCE
Pharm-Olam
Linical Accelovance
Accumedix, Inc.
AlcheraBio LLC
Amarex Clinical Research LLC
Arianne Corporation
Absolute Research Solutions
BioClinica Inc.
BioPharma Services Inc.
Neurovasc Preclinical Services, Inc.
PSI
WCCT Global Inc
RHO, Inc.
CATO Research LLC
Spaulding Clinical Research
Celerion
Clindatrix, Inc.
Comparative Biosciences, Inc.
Axiom Real-Time Metrics
CPC Clinical Research
Axis Clinicals LLC
DP Clinical
Egeen Inc.
Grayline
Cmed
Integrium, LLC
MedTrials
Novum
Shin Nippon Biomedical Laboratories, Ltd.
KPS Life
Pinnacle Research Group, LLC
Promedica International.
Alta Science
Prometrika, LLC
4clinics
Premier Research
“*” marked represents similar segmentation in other categories in the respective section.